logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
N

Nobuaki Ochi

Kawasaki Medical School
H指数:24
被引数:2,187

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ULK1, a novel therapeutic target to delay drug tolerance to EGFR-TKIs in an EGFR-mutant non-small cell lung cancer model

ULK1作为EGFR突变非小细胞肺癌模型中延迟EGFR-TKIs药物耐受的新型治疗靶点

Lung Cancer
IF4.4
2026-07-010
PRE
Morita, Ayako; Rai, Kammei; Kuribayashi, Tadahiro; Tomida, Shuta; Nishi, Tatsuya; Hara, Naofumi; Makimoto, Go; Ninomiya, Kiichiro; Kubo, Toshio; Ohashi, Kadoaki; Hotta, Katsuyuki; Ochi, Nobuaki; Togashi, Yosuke; Maeda, Yoshinobu; Ichihara, Eiki
Efficacy and safety of dose-dense chemotherapy for early-stage breast cancer under prophylactic pegfilgrastim administration: a systematic review and meta-analysis from clinical practice guidelines for the use of G-CSF 2022

剂量密集化疗在预防性使用培非格司亭的情况下对早期乳腺癌的疗效与安全性：一项基于《2022年G-CSF使用临床实践指南》的系统评价与荟萃分析

international journal of oncology
IF2.8
2025-02-120
PRE
Yokoe, Takamichi; Yoshinami, Tetsuhiro; Nozawa, Kazuki; Ozaki, Yukinori; Nishio, Hiroshi; Tsuchihashi, Kenji; Ichihara, Eiki; Miura, Yuji; Endo, Makoto; Yano, Shingo; Maruyama, Dai; Susumu, Nobuyuki; Takekuma, Munetaka; Motohashi, Takashi; Ito, Mamoru; Baba, Eishi; Ochi, Nobuaki; Kubo, Toshio; Uchino, Keita; Kamiyama, Yutaro; Nakao, Shinji; Tamura, Shinobu; Nishimoto, Hitomi; Kato, Yasuhisa; Sato, Atsushi; Takano, Toshimi
Impacts of probiotics on the efficacies of immune checkpoint inhibitors with or without chemotherapy for patients with advanced non-small-cell lung cancer
INTERNATIONAL JOURNAL OF CANCER
IF4.7
2024-01-095
PRE
Morita, Ayako; Ichihara, Eiki; Inoue, Koji; Fujiwara, Keiichi; Yokoyama, Toshihide; Harada, Daijiro; Ando, Chihiro; Kano, Hirohisa; Oda, Naohiro; Tamura, Tomoki; Ochi, Nobuaki; Kawai, Haruyuki; Inoue, Masaaki; Hara, Naofumi; Fujimoto, Nobukazu; Ichikawa, Hirohisa; Oze, Isao; Hotta, Katsuyuki; Maeda, Yoshinobu; Kiura, Katsuyuki
Response to letter re: The effects of antibiotics on the efficacy of immune-checkpoint inhibitors in non-small cell lung cancer patients differ according to PD-L1 expression

对letter re的回应: 抗生素对非小细胞肺癌患者免疫检查点抑制剂疗效的影响因PD-L1表达而异

EUROPEAN JOURNAL OF CANCER
IF7.1
2021-11-010
PREAI
Ochi, Nobuaki; Ichihara, Eiki; Takigawa, Nagio; Harada, Daijiro; Inoue, Koji; Shibayama, Takuo; Hosokawa, Shinobu; Kishino, Daizo; Harita, Shingo; Oda, Naohiro; Hara, Naofumi; Hotta, Katsuyuki; Maeda, Yoshinobu; Kiura, Katsuyuki
The effects of antibiotics on the efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancer differ based on PD-L1 expression

抗生素对非小细胞肺癌患者免疫检查点抑制剂疗效的影响基于PD-L1表达的差异

EUROPEAN JOURNAL OF CANCER
IF7.1
2021-05-0145
PREAI
Ochi, Nobuaki; Ichihara, Eiki; Takigawa, Nagio; Harada, Daijiro; Inoue, Koji; Shibayama, Takuo; Hosokawa, Shinobu; Kishino, Daizo; Harita, Shingo; Oda, Naohiro; Hara, Naofumi; Hotta, Katsuyuki; Maeda, Yoshinobu; Kiura, Katsuyuki
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study)
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2021-02-272
OAAI
Tanzawa, Shigeru; Ushijima, Sunao; Shibata, Kazuhiko; Shibayama, Takuo; Bessho, Akihiro; Kaira, Kyoichi; Misumi, Toshihiro; Shiraishi, Kenshiro; Matsutani, Noriyuki; Tanaka, Hisashi; Inaba, Megumi; Haruyama, Terunobu; Nakamura, Junya; Kishikawa, Takayuki; Nakashima, Masanao; Iwasa, Keiichi; Fujiwara, Keiichi; Kohyama, Tadashi; Kuyama, Shoichi; Miyazawa, Naoki; Nakamura, Tomomi; Miyawaki, Hiroshi; Ishida, Hiroo; Oda, Naohiro; Ishikawa, Nobuhisa; Morinaga, Ryotaro; Kusaka, Kei; Fujimoto, Nobukazu; Yokoyama, Toshihide; Gemba, Kenichi; Tsuda, Takeshi; Nakagawa, Hideyuki; Ono, Hirotaka; Shimizu, Tetsuo; Nakamura, Morio; Kusumoto, Sojiro; Hayashi, Ryuji; Shirasaki, Hiroki; Ochi, Nobuaki; Aoe, Keisuke; Kanaji, Nobuhiro; Kashiwabara, Kosuke; Inoue, Hiroshi; Seki, Nobuhiko
A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY)

一项前瞻性队列研究，以定义日本携带HER2畸变的肺癌的临床特征和结果 (HER2-CS研究)

CHEST
IF8.6
2019-08-0131
PREAI
Ninomiya, Kiichiro; Hata, Tae; Yoshioka, Hiroshige; Ohashi, Kadoaki; Bessho, Akihiro; Hosokawa, Shinobu; Ishikawa, Nobuhisa; Yamasaki, Masahiro; Shibayama, Takuo; Aoe, Keisuke; Kozuki, Toshiyuki; Harita, Shingo; Ueda, Yutaka; Murakami, Toshi; Fujimoto, Nobukazu; Yanai, Hiroyuki; Toyooka, Shinichi; Takata, Minoru; Hotta, Katsuyuki; Kiura, Katsuyuki; Gemba, K.; Ikeda, G.; Yasugi, M.; Kurimoto, E.; Nakano, K.; Moritaka, T.; Inoue, K.; Miyoshi, S.; Hamaguchi, N.; Ito, R.; Sano, Y.; Takata, I; Mitani, A.; Nishisaka, T.; Shoda, H.; Nishida, A.; Tamamoto, S.; Fujitaka, K.; Masuda, T.; Miyamoto, S.; Hattori, N.; Sugimoto, K.; Fujii, S.; Ueda, Y.; Sakugawa, M.; Fukamatsu, N.; Ogata, Y.; Bandoh, S.; Kanaji, N.; Takigawa, N.; Yamane, H.; Ochi, N.; Honda, Y.; Oka, M.; Kittaka, M.; Kubota, T.; Yokoyama, A.; Yokoyama, T.; Sato, E.; Shiota, Y.; Horita, N.; Kanematsu, T.; Awaya, Y.; Nakamasu, A.; Murakami, I; Kuyama, S.; Kudo, K.; Tamura, T.; Umeno, T.; Morichika, D.; Fujiwara, K.; Sato, K.; Harada, D.; Nogami, N.; Nishii, K.; Fuchimoto, Y.; Kishimoto, T.; Kawai, H.; Watanabe, K.; Tokumo, K.; Isobe, T.; Tsubata, Y.; Inoue, M.; Ichikawa, H.; Nishioka, Y.; Hanibuchi, M.; Goto, H.; Sumikawa, T.; Kodani, M.; Suyama, H.; Makino, H.; Kinosita, N.; Shimizu, E.; Obata, H.; Ikegami, H.; Chikamori, K.; Maeda, T.; Kishino, T.; Kamei, H.; Ueoka, H.; Kunihiro, Y.; Kobayashi, T.; Ueda, K.; Hayashi, M.; Kamiya, M.; Murakami, J.; Sato, A.; Ichihara, E.; Kubo, T.; Ninomiya, T.; Hirata, T.; Minami, D.; Kato, Y.; Higo, H.; Makimoto, G.; Toyota, Y.; Oda, N.; Nakanishi, M.; Kayatani, H.; Senoo, S.; Kano, H.; Watanabe, H.; Ando, T.; Nakasuka, T.; Hara, N.; Itano, J.; Nakashima, H.; Tabata, M.
Wandering consolidation
THORAX
IF7.7
2019-05-291
OAAI
Kawahara, Tatsuyuki; Ochi, Nobuaki; Kato, Katsuya; Shibamoto, Kentaro; Nagasaki, Yasunari; Nakagawa, Nozomu; Nakanishi, Hidekazu; Yamane, Hiromichi; Monobe, Yasumasa; Takigawa, Nagio
Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol
CLINICAL LUNG CANCER
IF3.3
2019-03-0120
PREAI
Ninomiya, Takashi; Ishikawa, Nobuhisa; Inoue, Koji; Kubo, Toshio; Yasugi, Masayuki; Shibayama, Takuo; Maeda, Tadashi; Fujitaka, Kazunori; Kodani, Masahiro; Yokoyama, Toshihide; Kuyama, Shoichi; Ochi, Nobuaki; Ueda, Yutaka; Miyoshi, Seigo; Kozuki, Toshiyuki; Amano, Yoshihiro; Kubota, Tetsuya; Sugimoto, Keisuke; Bessho, Akihiro; Ishii, Tomoya; Watanabe, Kazuhiko; Oze, Isao; Hotta, Katsuyuki; Kiura, Katsuyuki
Activating alternative receptor tyrosine kinases induced alectinib-resistance in ALK rearranged non-small cell lung cancer cells
CANCER RESEARCH
IF16.6
2016-07-150
PRE
Isozaki, Hideko; Ichihara, Eiki; Yasugi, Masayuki; Takigawa, Nagio; Ohashi, Kadoaki; Kubo, Toshio; Ninomiya, Takashi; Ochi, Nobuaki; Minami, Daisuke; Kudo, Kenichiro; Kato, Yuka; Kayatani, Hiroe; Tamura, Tomoki; Ninonniya, Kiichiro; Higo, Toshio; Makimoto, Tsuyoshi; Sato, Akiko; Hotta, Katsuyuki; Matsumoto, Kunio; Sendo, Toshiaki; Tanimoto, Mitsune; Kiura, Katsuyuki

研究方向

暂未获取到该数据
N
Nagio Takigawa
H 指数:45论文数:565被引数:1.6万
K
Katsuyuki Kiura
H 指数:64论文数:1,029被引数:1.7万
H
Hiromichi Yamane
H 指数:17论文数:162被引数:1,233
E
Eiki Ichihara
H 指数:38论文数:503被引数:7,170
K
Katsuyuki Hotta
H 指数:52论文数:649被引数:3.1万
M
Mitsune Tanimoto
H 指数:67论文数:971被引数:1.8万
K
Kadoaki Ohashi
H 指数:30论文数:362被引数:7,942
D
Daijiro Harada
H 指数:22论文数:154被引数:2,391
T
Toshio Kubo
H 指数:30论文数:275被引数:3,796
M
Masayuki Yasugi
H 指数:13论文数:84被引数:525